Article ; Online: Antioxidant enzyme gene transfer for ischemic diseases.
Advanced drug delivery reviews
2009 Volume 61, Issue 4, Page(s) 351–363
Abstract: ... the therapeutic benefits and potential risks, to develop disease-specific antioxidant gene transfer strategies ... free radical scavengers and their mimetics, as well as gene transfer approaches to overexpress antioxidant genes represent ... potential therapeutic options to correct the redox imbalance. Among them, antioxidant gene transfer ...
| Abstract | The balance of redox is pivotal for normal function and integrity of tissues. Ischemic insults occur as results of a variety of conditions, leading to an accumulation of reactive oxygen species (ROS) and an imbalanced redox status in the tissues. The oxidant stress may activate signaling mechanisms provoking more toxic events, and eventually cause tissue damage. Therefore, treatments with antioxidants, free radical scavengers and their mimetics, as well as gene transfer approaches to overexpress antioxidant genes represent potential therapeutic options to correct the redox imbalance. Among them, antioxidant gene transfer may enhance the production of antioxidant scavengers, and has been employed to experimentally prevent or treat ischemic injury in cardiovascular, pulmonary, hepatic, intestinal, central nervous or other systems in animal models. With improvements in vector systems and delivery approaches, innovative antioxidant gene therapy has conferred better outcomes for myocardial infarction, reduced restenosis after coronary angioplasty, improved the quality and function of liver grafts, as well as outcome of intestinal and cerebral ischemic attacks. However, it is crucial to be mindful that like other therapeutic armentarium, the efficacy of antioxidant gene transfer requires extensive preclinical investigation before it can be used in patients, and that it may have unanticipated short- or long-term adverse effects. Thus, it is critical to balance between the therapeutic benefits and potential risks, to develop disease-specific antioxidant gene transfer strategies, to deliver the therapy with an optimal time window and in a safe manner. This review attempts to provide the rationale, the most effective approaches and the potential hurdles of available antioxidant gene transfer approaches for ischemic injury in various organs, as well as the possible directions of future preclinical and clinical investigations of this highly promising therapeutic modality. |
|---|---|
| MeSH term(s) | Animals ; Antioxidants/administration & dosage ; Gene Transfer Techniques/trends ; Genetic Therapy/methods ; Genetic Therapy/trends ; Humans ; Ischemia/enzymology ; Ischemia/genetics ; Ischemia/therapy ; Oxidative Stress/drug effects ; Oxidative Stress/genetics ; Reactive Oxygen Species/metabolism |
| Chemical Substances | Antioxidants ; Reactive Oxygen Species |
| Language | English |
| Publishing date | 2009-02-20 |
| Publishing country | Netherlands |
| Document type | Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, Non-P.H.S. ; Review |
| ZDB-ID | 639113-8 |
| ISSN | 1872-8294 ; 0169-409X |
| ISSN (online) | 1872-8294 |
| ISSN | 0169-409X |
| DOI | 10.1016/j.addr.2009.01.005 |
| Database | MEDical Literature Analysis and Retrieval System OnLINE |
Full text online
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
| Zs.A 2241: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.